NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Prisys Biotechnology Co., Ltd.

Prisys Biotechnology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://www.prisysbiotech.com/

Last Round

VC Round

Jun 7, 2021

Total Funding Raised

$28.83M

Company Overview

Prisys Biotechnology Co., Ltd. is a biotechnology company that provides preclinical and quasi-clinical evaluation services, including non-human primate disease models and pharmacology research, to support drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

contract research organizationCROnon-human primate modelsNHP modelspreclinical drug developmenttranslational medicinebehavioral analysissafety assessmenttoxicologyIND-enabling studiesprecision CNS administrationAI-driven analyticsdrug discovery servicesdigital twinanimal research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prisys Biotechnology Co., Ltd. Comparables

Compare Prisys Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Prisys Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kunming Biomed International
86%
Virscio
85%
PharmaLegacy
85%

Prisys Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 7, 2021
Series BNov 16, 2020
Pre SeedMay 1, 2017
AngelApr 1, 2016

Prisys Biotechnology Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 7, 2021

    Completed a venture round of funding.

  • Nov 16, 2020

    $21M round with participation from ZhenFund and others.

Prisys Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prisys Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prisys Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range32
Year FoundedN/A
Last FundingJun 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.